Zene is a startup that determines "lifetime invariant disease risk" through individual genetic analysis and supports countermeasures. The difference between the company's genetic analysis service and conventional genetic testing is that it uses a "polygenic risk score method" that comprehensively analyzes the entire genomic information. Instead of the conventional method of dividing several genes by type and providing the proportion of diseased people, AI is used to comprehensively test more gene information, so the analysis accuracy will be higher.

Zene (株式会社Zene)

Zene (株式会社Zene)